AGP Picks
View all

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on August 11, 2026

Zus Health Accepted as a Candidate QHIN Under TEFCA
Folia Health Launches FSGS PULSE Study to Generate a More Complete Understanding of FSGS Disease Burden and Treatment
Zus Health Achieves HITRUST r2 Certification, Demonstrating Commitment to Cybersecurity and Information Protection
Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter
CarGurus Names 2026 Top Dealer Award Winners
Gordon Brothers Closes Inaugural $265M Asset-Backed Securitization
Advanced Chip Packaging Technologies Market to Reach $87.6 Billion by 2030, Driven by AI and High-Performance Computing Demand
The Rise of the “Disposable” American Worker
SparkCharge Launches in the United Kingdom, Bringing AI-Optimized Energy Infrastructure to Autonomous Vehicle Fleet Operations Without the Wait
MDaudit Ranked the 232nd Fastest-Growing Private Healthcare & Medical Company on the Inc. 5000
Wolf & Company Named #1 Fastest Growing Organic Accounting Firm With Multiple 2026 List Recognitions
 Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or…
Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth
Constant Therapy Health Launches Web Platform for Speech, Language, and Cognitive Therapy
Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer
Harvard Bioscience Announces Second Quarter 2026 Financial Results
C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Upstream Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Progress

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Massachusetts Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.